Daniel Gines

Daniel Gines serves as a key procurement lead at the Naval Medical Research Center, supporting the Department of the Navy’s mission to enhance force health protection through advanced biomedical innovation. He manages a portfolio of acquisitions focused on laboratory instrumentation, diagnostic systems, and field-deployable medical technologies critical to operational readiness in austere environments. His responsibilities include soliciting, evaluating, and awarding contracts for research-grade analytical equipment, precision diagnostic tools, and specialized medical supply chains, ensuring alignment with DoD standards for reliability and rapid deployment. Gines plays a central role in translating scientific requirements into actionable procurement strategies that accelerate the transition of research outputs into operational use. Gines maintains a consistent working relationship with REES SCIENTIFIC CORPORATION, a primary vendor providing laboratory automation, diagnostic reagents, and precision instrumentation tailored to military medical research needs. His contracting patterns reflect long-term, performance-based partnerships with technical specialists rather than broad commodity suppliers, indicating a preference for vendors with proven expertise in biomedical R&D support. These relationships are characterized by repeat engagements, technical collaboration, and a focus on validated, mission-critical solutions. Gines’ procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability and performance over socioeconomic preferences, prioritizing the most qualified providers regardless of business size or certification status. While small business participation is not formally incentivized, the nature of the technical requirements often naturally attracts niche firms with specialized expertise. His primary NAICS focus areas include 811219 (precision equipment repair and maintenance), 334516 (analytical laboratory instrument manufacturing), and 541714 (biotechnology R&D), underscoring deep expertise in procuring diagnostic systems, lab automation, and proprietary biomedical research tools. He consistently sources high-specification equipment for infectious disease detection, point-of-care diagnostics, and field-deployable analytical platforms used in global operational theaters.